ID   EPHA5_RAT               Reviewed;        1005 AA.
AC   P54757;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   29-SEP-2021, entry version 178.
DE   RecName: Full=Ephrin type-A receptor 5;
DE            EC=2.7.10.1;
DE   AltName: Full=EPH homology kinase 1;
DE            Short=EHK-1;
DE   Flags: Precursor;
GN   Name=Epha5; Synonyms=Ehk-1, Ekh1, Rek7;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4 AND 5).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7504232;
RA   Maisonpierre P.C., Barrezueta N.X., Yancopoulos G.D.;
RT   "Ehk-1 and Ehk-2: two novel members of the Eph receptor-like tyrosine
RT   kinase family with distinctive structures and neuronal expression.";
RL   Oncogene 8:3277-3288(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7898646; DOI=10.1016/0306-4522(94)90014-0;
RA   Taylor V., Miescher G.C., Pfarr S., Honegger P., Breitschopf H.,
RA   Lassmann H., Steck A.J.;
RT   "Expression and developmental regulation of Ehk-1, a neuronal Elk-like
RT   receptor tyrosine kinase in brain.";
RL   Neuroscience 63:163-178(1994).
RN   [3]
RP   FUNCTION IN AXON GUIDANCE, AND SUBCELLULAR LOCATION.
RX   PubMed=7748564; DOI=10.1016/0896-6273(95)90335-6;
RA   Winslow J.W., Moran P., Valverde J., Shih A., Yuan J.Q., Wong S.C.,
RA   Tsai S.P., Goddard A., Henzel W.J., Hefti F., Beck K.D., Caras I.W.;
RT   "Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor
RT   involved in axon bundle formation.";
RL   Neuron 14:973-981(1995).
RN   [4]
RP   FUNCTION IN SYNAPTIC PLASTICITY, AND TISSUE SPECIFICITY.
RX   PubMed=9698392; DOI=10.1006/mcne.1998.0696;
RA   Gao W.Q., Shinsky N., Armanini M.P., Moran P., Zheng J.L.,
RA   Mendoza-Ramirez J.L., Phillips H.S., Winslow J.W., Caras I.W.;
RT   "Regulation of hippocampal synaptic plasticity by the tyrosine kinase
RT   receptor, REK7/EphA5, and its ligand, AL-1/Ephrin-A5.";
RL   Mol. Cell. Neurosci. 11:247-259(1998).
RN   [5]
RP   FUNCTION IN SYNAPTOGENESIS, EFNA5 LIGAND-BINDING, SUBCELLULAR LOCATION, AND
RP   PHOSPHORYLATION.
RX   PubMed=20824214; DOI=10.1371/journal.pone.0012486;
RA   Akaneya Y., Sohya K., Kitamura A., Kimura F., Washburn C., Zhou R.,
RA   Ninan I., Tsumoto T., Ziff E.B.;
RT   "Ephrin-A5 and EphA5 interaction induces synaptogenesis during early
RT   hippocampal development.";
RL   PLoS ONE 5:E12486-E12486(2010).
CC   -!- FUNCTION: Receptor tyrosine kinase which binds promiscuously GPI-
CC       anchored ephrin-A family ligands residing on adjacent cells, leading to
CC       contact-dependent bidirectional signaling into neighboring cells. The
CC       signaling pathway downstream of the receptor is referred to as forward
CC       signaling while the signaling pathway downstream of the ephrin ligand
CC       is referred to as reverse signaling. Among GPI-anchored ephrin-A
CC       ligands, EFNA5 most probably constitutes the cognate/functional ligand
CC       for EPHA5. Functions as an axon guidance molecule during development
CC       and may be involved in the development of the retinotectal, entorhino-
CC       hippocampal and hippocamposeptal pathways. Together with EFNA5 plays
CC       also a role in synaptic plasticity in adult brain through regulation of
CC       synaptogenesis. In addition to its function in the nervous system, the
CC       interaction of EPHA5 with EFNA5 mediates communication between
CC       pancreatic islet cells to regulate glucose-stimulated insulin secretion
CC       (By similarity). {ECO:0000250, ECO:0000269|PubMed:20824214,
CC       ECO:0000269|PubMed:7748564, ECO:0000269|PubMed:9698392}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- SUBUNIT: Heterotetramer upon binding of the ligand. The heterotetramer
CC       is composed of an ephrin dimer and a receptor dimer. Oligomerization is
CC       probably required to induce biological responses (By similarity).
CC       Interacts (via SAM domain) with SAMD5 (via SAM domain) (By similarity).
CC       {ECO:0000250, ECO:0000250|UniProtKB:Q60629}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20824214,
CC       ECO:0000269|PubMed:7748564}; Single-pass type I membrane protein
CC       {ECO:0000255}. Cell projection, axon {ECO:0000269|PubMed:20824214,
CC       ECO:0000269|PubMed:7748564}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:P54756}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P54757-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P54757-2; Sequence=VSP_003001;
CC       Name=3;
CC         IsoId=P54757-3; Sequence=VSP_003002;
CC       Name=4;
CC         IsoId=P54757-4; Sequence=VSP_003002, VSP_003003;
CC       Name=5;
CC         IsoId=P54757-5; Sequence=VSP_003001, VSP_003002, VSP_003003;
CC   -!- TISSUE SPECIFICITY: Almost exclusively expressed in the nervous system.
CC       Predominantly expressed in neurons. {ECO:0000269|PubMed:9698392}.
CC   -!- PTM: Phosphorylated. Phosphorylation is stimulated by the ligand EFNA5.
CC       Dephosphorylation upon stimulation by glucose, inhibits EPHA5 forward
CC       signaling and results in insulin secretion (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION: [Isoform 3]:
CC       Sequence=CAA55357.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X78689; CAA55357.1; ALT_FRAME; mRNA.
DR   PIR; PT0186; PT0186.
DR   PIR; S47489; S47489.
DR   PIR; S49015; S49015.
DR   PIR; S51603; S51603.
DR   PIR; S51604; S51604.
DR   RefSeq; NP_077343.1; NM_024367.1.
DR   SMR; P54757; -.
DR   STRING; 10116.ENSRNOP00000002793; -.
DR   GuidetoPHARMACOLOGY; 1825; -.
DR   GlyGen; P54757; 6 sites.
DR   iPTMnet; P54757; -.
DR   PhosphoSitePlus; P54757; -.
DR   SwissPalm; P54757; -.
DR   jPOST; P54757; -.
DR   PaxDb; P54757; -.
DR   PRIDE; P54757; -.
DR   GeneID; 79208; -.
DR   KEGG; rno:79208; -.
DR   UCSC; RGD:620831; rat. [P54757-1]
DR   CTD; 2044; -.
DR   RGD; 620831; Epha5.
DR   eggNOG; KOG0196; Eukaryota.
DR   InParanoid; P54757; -.
DR   OrthoDB; 933071at2759; -.
DR   PhylomeDB; P54757; -.
DR   BRENDA; 2.7.10.1; 5301.
DR   Reactome; R-RNO-2682334; EPH-Ephrin signaling.
DR   Reactome; R-RNO-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-RNO-3928665; EPH-ephrin mediated repulsion of cells.
DR   PRO; PR:P54757; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005912; C:adherens junction; ISO:RGD.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:0071944; C:cell periphery; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005003; F:ephrin receptor activity; IDA:UniProtKB.
DR   GO; GO:0005004; F:GPI-linked ephrin receptor activity; ISS:UniProtKB.
DR   GO; GO:0019838; F:growth factor binding; IPI:ARUK-UCL.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0005005; F:transmembrane-ephrin receptor activity; IBA:GO_Central.
DR   GO; GO:0007411; P:axon guidance; ISS:UniProtKB.
DR   GO; GO:0019933; P:cAMP-mediated signaling; IDA:UniProtKB.
DR   GO; GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; ISO:RGD.
DR   GO; GO:1904322; P:cellular response to forskolin; ISO:RGD.
DR   GO; GO:0060997; P:dendritic spine morphogenesis; IDA:UniProtKB.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0021766; P:hippocampus development; ISS:UniProtKB.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; IDA:MGI.
DR   GO; GO:0048666; P:neuron development; ISO:RGD.
DR   GO; GO:0032793; P:positive regulation of CREB transcription factor activity; IMP:UniProtKB.
DR   GO; GO:0033674; P:positive regulation of kinase activity; IBA:GO_Central.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0043087; P:regulation of GTPase activity; ISS:UniProtKB.
DR   GO; GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 1.10.150.50; -; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR027936; Eph_TM.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016257; Tyr_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_kinase_rcpt_V_CS.
DR   Pfam; PF14575; EphA2_TM; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS51550; EPH_LBD; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Cell projection;
KW   Glycoprotein; Kinase; Membrane; Neurogenesis; Nucleotide-binding;
KW   Phosphoprotein; Receptor; Reference proteome; Repeat; Signal; Transferase;
KW   Transmembrane; Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000250"
FT   CHAIN           27..1005
FT                   /note="Ephrin type-A receptor 5"
FT                   /id="PRO_0000016814"
FT   TOPO_DOM        27..575
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        576..596
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        597..1005
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          62..240
FT                   /note="Eph LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00883"
FT   DOMAIN          359..469
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          470..564
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          677..938
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          967..1005
FT                   /note="SAM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   NP_BIND         683..691
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..24
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        802
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         709
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         652
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         658
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         835
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         984
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        266
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        301
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        371
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        425
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        438
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        463
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT                   /id="VSP_003000"
FT   VAR_SEQ         306..357
FT                   /note="VCRPGFFKASPHSQTCSKCPPHSYTHEEASTSCVCEKDYFRRESDPPTMACT
FT                   -> G (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:7504232"
FT                   /id="VSP_003001"
FT   VAR_SEQ         358..470
FT                   /note="RPPSAPRNAISNVNETSVFLEWIPPADTGGGKDVSYYILCKKCNSHAGVCEE
FT                   CGGHVRYLPQQIGLKNTSVMMADPLAHTNYTFEIEAVNGVSDLSPGTRQYVSVNVTTNQ
FT                   AA -> T (in isoform 3, isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:7504232,
FT                   ECO:0000303|PubMed:7898646"
FT                   /id="VSP_003002"
FT   VAR_SEQ         597..621
FT                   /note="SGSCCECGCGRASSLCAVAHPSLIW -> R (in isoform 4 and
FT                   isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:7504232"
FT                   /id="VSP_003003"
FT   CONFLICT        170
FT                   /note="D -> E (in Ref. 2; CAA55357)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        566
FT                   /note="G -> A (in Ref. 2; CAA55357)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        578
FT                   /note="G -> A (in Ref. 2; CAA55357)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        669
FT                   /note="G -> A (in Ref. 2; CAA55357)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        708
FT                   /note="T -> I (in Ref. 2; CAA55357)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        979
FT                   /note="T -> I (in Ref. 2; CAA55357)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1005 AA;  111007 MW;  1AED42C99693C574 CRC64;
     MRGSGPRGAG RRRTQGRGGG GDTPRVPASL AGCYSAPLKG PLWTCLLLCA ALRTLLASPS
     NEVNLLDSRT VLGDLGWIAF PKNGWEEIGE VDENYAPIHT YQVCKVMEQN QNNWLLTSWI
     SNEGASRIFI ELKFTLRDCN SLPGGLGTCK ETFNMYYFES DDENGRNIKD NQYIKIDTIA
     ADESFTELDL GDRVMKLNTE VRDVGPLSKK GFYLAFQDVG ACIALVSVRV YYKKCPSVVR
     HLAVFPDTIT GADSSQLLEV SGSCVNHSVT DDPPKMHCSA EGEWLVPIGK CMCKAGYEEK
     NGTCQVCRPG FFKASPHSQT CSKCPPHSYT HEEASTSCVC EKDYFRRESD PPTMACTRPP
     SAPRNAISNV NETSVFLEWI PPADTGGGKD VSYYILCKKC NSHAGVCEEC GGHVRYLPQQ
     IGLKNTSVMM ADPLAHTNYT FEIEAVNGVS DLSPGTRQYV SVNVTTNQAA PSPVTNVKKG
     KIAKNSISLS WQEPDRPNGI ILEYEIKYFE KDQETSYTII KSKETTITAE GLKPASVYVF
     QIRARTAAGY GVFSRRFEFE TTPVFGASND QSQIPIIGVS VTVGVILLAV MIGFLLSGSC
     CECGCGRASS LCAVAHPSLI WRCGYSKAKQ DPEEEKMHFH NGHIKLPGVR TYIDPHTYED
     PTQAVHEFGK EIEASCITIE RVIGAGEFGE VCSGRLKLPG KRELPVATKT LKVGYTEKQR
     RDFLSEASIM GQFDHPNIIH LEGVVTKSKP VMIVTEYMEN GSLDTFLKKN DGQFTVIQLV
     GMLRGIAAGM KYLSDMGYVH RDLAARNILI NSNLVCKVSD FGLSRVLEDD PEAAYTTRGG
     KIPIRWTAPE AIAFRKFTSA SDVWSYGIVM WEVVSYGERP YWEMTNQDVI KAVEEGYRLP
     SPMDCPAALY QLMLDCWQKD RNSRPKFDDI VNMLDKLIRN PSSLKTLVNA SSRVSTLLAE
     HGSLGSGAYR SVGEWLEATK MGRYTEIFME NGYSSMDAVA QVTLE
//